Another potential reason for the lack of a correlation included a decrease in serum KL-6 levels by treatment with CYC or MMF in patients with SSc-ILD, independent of the improvement or deterioration of pulmonary function [16,17]. This evidence concerns the gene MUC1 and systemic sclerosis.